Biology:TRPV5

From HandWiki
Revision as of 03:04, 12 February 2024 by Jslovo (talk | contribs) (url)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Transient receptor potential cation channel subfamily V member 5 is a calcium channel protein that in humans is encoded by the TRPV5 gene.[1][2][3]

Function

The TRPV5 gene is a member of the transient receptor family and the TRPV subfamily. The calcium-selective channel, TRPV5, encoded by this gene has 6 transmembrane-spanning domains, multiple potential phosphorylation sites, an N-linked glycosylation site, and 5 ANK repeats. This protein forms homotetramers or heterotetramers and is activated by a low internal calcium level.[4]

Both TRPV5 and TRPV6 are expressed in kidney and intestinal epithelial cells.[5] TRPV5 is mainly expressed in kidney epithelial cells, where it plays an important role in the reabsorption of Ca2+,[6] whereas TRPV6 is mainly expressed in the intestine.[5] The enzyme α-klotho increases kidney calcium reabsorption by stabilizing TPRV5.[5] Klotho is a beta-glucuronidase-like enzyme that activates TRPV5 by removal of sialic acid.[7]

Clinical significance

Normally, about 95% to 98% of Ca2+ filtered from the blood by the kidney is reabsorbed by the kidney's renal tubule, mediated by TRPV5.[8] Genetic deletion of TRPV5 in mice leads to Ca2+ loss in the urine, and consequential hyperparathyroidism, and bone loss.[9]

Inhibitors

  • Econazole is a weak inhibitor of both TRPV5 and TRPV6, with an IC50 in the micromolar range
  • ZINC17988990 is a potent and selective inhibitor of TRPV5, with an IC50 of 177nM and good selectivity over TRPV6 and the other TRPV channel subtypes.[10]

Interactions

TRPV5 has been shown to interact with S100A10.[11]

See also

References

  1. "Gene structure and chromosomal mapping of human epithelial calcium channel". Biochemical and Biophysical Research Communications 275 (1): 47–52. August 2000. doi:10.1006/bbrc.2000.3227. PMID 10944439. 
  2. "Molecular cloning, tissue distribution, and chromosomal mapping of the human epithelial Ca2+ channel (ECAC1)". Genomics 67 (1): 48–53. July 2000. doi:10.1006/geno.2000.6203. PMID 10945469. 
  3. "International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels". Pharmacological Reviews 57 (4): 427–50. December 2005. doi:10.1124/pr.57.4.6. PMID 16382100. 
  4. "Entrez Gene: TRPV5 transient receptor potential cation channel, subfamily V, member 5". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=56302. 
  5. 5.0 5.1 5.2 "TRP channels in calcium homeostasis: from hormonal control to structure-function relationship of TRPV5 and TRPV6". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864 (6): 883–893. June 2017. doi:10.1016/j.bbamcr.2016.11.027. PMID 27913205. 
  6. "Molecular mechanism of active Ca2+ reabsorption in the distal nephron". Annual Review of Physiology 64: 529–49. 2002. doi:10.1146/annurev.physiol.64.081501.155921. PMID 11826278. 
  7. "Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1". Proceedings of the National Academy of Sciences of the United States of America 105 (28): 9805–10. July 2008. doi:10.1073/pnas.0803223105. PMID 18606998. Bibcode2008PNAS..105.9805C. 
  8. "Klotho up-regulates renal calcium channel transient receptor potential vanilloid 5 (TRPV5) by intra- and extracellular N-glycosylation-dependent mechanisms". The Journal of Biological Chemistry 289 (52): 35849–57. December 2014. doi:10.1074/jbc.M114.616649. PMID 25378396. 
  9. "Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5". The Journal of Clinical Investigation 112 (12): 1906–14. December 2003. doi:10.1172/JCI19826. PMID 14679186. 
  10. "Structure-based characterization of novel TRPV5 inhibitors". eLife 8. October 2019. doi:10.7554/eLife.49572. PMID 31647410. 
  11. "Functional expression of the epithelial Ca(2+) channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex". The EMBO Journal 22 (7): 1478–87. April 2003. doi:10.1093/emboj/cdg162. PMID 12660155. 

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.